Weatherstone Capital Management’s AstraZeneca AZN Stock Holding History

Weatherstone Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,019	Closed	-$264K	–	102
2016 Q3	$264K	Hold	4,019	–	–	0.22%	74
2016 Q2	$243K	Hold	4,019	–	–	0.21%	73
2016 Q1	$226K	Hold	4,019	–	–	0.16%	74
2015 Q4	$273K	Hold	4,019	–	–	0.31%	60
2015 Q3	$256K	Hold	4,019	–	–	0.24%	47
2015 Q2	$256K	Hold	4,019	–	–	0.23%	60
2015 Q1	$281K	Hold	4,019	–	–	0.17%	61
2014 Q4	$284K	Hold	4,019	–	–	0.17%	55
2014 Q3	$289K	Hold	4,019	–	–	0.15%	41
2014 Q2	$299K	Hold	4,019	–	–	0.08%	55
2014 Q1	$262K	Hold	4,019	–	–	0.08%	48
2013 Q4	$239K	Hold	4,019	–	–	0.05%	60
2013 Q3	$208K	Buy	+4,019	New	+$202K	0.05%	55

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Weatherstone Capital Management's AZN Position: Q4 2016 in Review

Weatherstone Capital Management sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 4,019 shares — an estimated $264K sold.

Weatherstone Capital Management first reported a position in AZN in Q3 2013 and held it in 13 quarters. The position peaked at $299K in Q2 2014. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

Weatherstone Capital Management reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
Weatherstone Capital Management sold 4,019 AstraZeneca shares in Q4 2016, an estimated $264K.
Weatherstone Capital Management first reported a position in AstraZeneca in Q3 2013 and held it in 13 quarters.
Weatherstone Capital Management's AstraZeneca position peaked at $299K in Q2 2014.
450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on Weatherstone Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.